These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2658906)
1. DNA content in human cancer. Application in pathology and clinical medicine. Seckinger D; Sugarbaker E; Frankfurt O Arch Pathol Lab Med; 1989 Jun; 113(6):619-26. PubMed ID: 2658906 [TBL] [Abstract][Full Text] [Related]
2. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Kallioniemi OP Cytometry; 1988 Mar; 9(2):164-9. PubMed ID: 3359893 [TBL] [Abstract][Full Text] [Related]
3. [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters]. Araya JC; Roa I; Wistuba I; Villaseca MA; Contreras E; Olcese A; Danton A; Watanabe H Rev Med Chil; 1994 Jun; 122(6):643-52. PubMed ID: 7732208 [TBL] [Abstract][Full Text] [Related]
4. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry. Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938 [TBL] [Abstract][Full Text] [Related]
5. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Meyer JS; Gersell DJ; Yim S Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140 [TBL] [Abstract][Full Text] [Related]
6. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Chen TL; Luo I; Mikhail N; Rasková J; Raska K Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949 [TBL] [Abstract][Full Text] [Related]
7. DNA flow cytometry in solid tumors: practical aspects and clinical applications. Dressler LG; Bartow SA Semin Diagn Pathol; 1989 Feb; 6(1):55-82. PubMed ID: 2645625 [TBL] [Abstract][Full Text] [Related]
8. DNA ploidy and proliferation heterogeneity in human prostate cancers. Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306 [TBL] [Abstract][Full Text] [Related]
10. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Hedley DW; Rugg CA; Gelber RD Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170 [TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696 [TBL] [Abstract][Full Text] [Related]
12. [Possibilities of DNA impulse cytophotometry in kidney cancers]. Kiesewetter F; Hornstein OP; Hermanek P; Herrlinger A; Eberhard S Urologe A; 1987 May; 26(3):162-7. PubMed ID: 3603902 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of primary cervical and vulvar carcinomas and their metastases. Siracký J; Kysela B; Siracká E Neoplasma; 1989; 36(4):437-45. PubMed ID: 2770930 [TBL] [Abstract][Full Text] [Related]
14. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer. Bittard H; Lamy B; Billery C J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280 [TBL] [Abstract][Full Text] [Related]
16. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometry of histological material from human gastric cancer. Macartney JC; Camplejohn RS; Powell G J Pathol; 1986 Apr; 148(4):273-7. PubMed ID: 3701493 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of DNA ploidy in breast cancer stage I-II. Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]